Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
News Alert: FDA highlights safety issue with leadless pacemakers
Thursday, November 18, 2021
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

News Alert

FDA highlights safety issue with leadless pacemakers, focusing on Medtronic’s Micra

All pacemakers are associated with a risk of cardiac perforation, the agency said, but perforation-related complications appear to be more severe with leadless pacing systems.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

FDA highlights safety issue with leadless pacemakers, focusing on Medtronic’s Micra

Share on Twitter Share on Facebook Share on Linkedin
All pacemakers are associated with a risk of cardiac perforation, the agency said, but perforation-related complications appear to be more severe with leadless pacing systems.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

J&J MedTech ordered to pay $147M for antitrust violations | Skipping the cardiologist | Active patients live longer
Changes in cardiologist employment | Robotic PCI is safe & effective | Banksy auction will fund research | AI tracks blood clots
Week in Review: When TAVR valves fail | A new use for IVL | Semaglutide works fast | Obicetrapib in high-risk patients
Comparing intra-annular TAVR valves | Abbott's FreeStyle Libre makes an impact | Imaging & chest pain | The benefits of Barostim
Cardiology groups speak up | Seeking answers after the FDA approved TAVR for asymptomatic AS | SDD after cardiac ablation
Key details about PCI after TAVR | Cardiology groups oppose Medicaid cuts | Semaglutide works fast | Reframing leadership myths
Surgery, not TAVR, still preferred for some patients | Drug helps surgeons avoid a 'bloody mess' | Robotic mitral valve repair

Pagination

    • First page « First
    • Previous page ‹‹
    • Page …79
    • Page 80
    • Page 81
    • Page 82
    • Current page 83
    • Page 84
    • Page 85
    • Page 86
    • Page 87 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme